论文部分内容阅读
从细胞培养角度对慢性再障（ＣＡＡ）的疗效机理及中医辨证分型的客观指标进行了深入的探讨，结果显示补髓生血胶囊治疗慢性再障其作用环节是多方位的。它既能促进再障患者造血干／祖细胞增殖，改善造血微环境，又能修复机体免疫力。且疗效优于再障生血片。还通过本方治疗慢性再障患者前后血象变化观察，并与已知治疗再障的药物再障生血片比较，结果提示本方对回升白细胞、血红蛋白方面确实有明显的优势。
From the perspective of cell culture, the therapeutic mechanism of chronic aplastic anemia (CAA) and the objective indicators of TCM syndrome differentiation were discussed in depth. The results showed that the action of Bupeng Shengxue Capsules in treating chronic aplastic anemia is multifaceted. It can not only promote the proliferation of hematopoietic stem/progenitor cells in patients with aplastic anemia, improve the hematopoietic microenvironment, but also repair the body immunity. And the curative effect is better than that of Aplastic Blood Tablets. We also observed blood changes before and after the treatment of patients with chronic aplastic anemia, and compared with known aplastic anemia drug blood tablets, the results suggest that this party does have a clear advantage in the recovery of white blood cells, hemoglobin.